DISTRIBUTION OF CD4(+) T-LYMPHOCYTES AT DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME-DEFINING AND OTHER HUMAN IMMUNODEFICIENCY VIRUS-RELATED ILLNESSES

被引:100
作者
HANSON, DL
CHU, SY
FARIZO, KM
WARD, JW
STETLER, HC
SORVILLO, F
BUSKIN, SE
SHANER, KL
MOKOTOFF, E
DAVIDSON, A
TROXLER, SH
PHELPS, AF
CORONADO, VG
机构
[1] GEORGIA DEPT HUMAN RESOURCES, ATLANTA, GA USA
[2] LOS ANGELES CTY DEPT HLTH SERV, LOS ANGELES, CA USA
[3] SEATTLE KING CTY DEPT PUBL HLTH, SEATTLE, WA USA
[4] TEXAS DEPT HLTH, AUSTIN, TX USA
[5] MICHIGAN DEPT PUBL HLTH, DETROIT, MI USA
[6] DENVER DEPT HLTH & HOSP, DENVER, CO USA
[7] LOUISIANA DEPT HLTH & HOSP, NEW ORLEANS, LA USA
[8] HLTH & HUMAN SERV DEPT, HOUSTON, TX USA
[9] NEW YORK CITY DEPT HLTH, NEW YORK, NY 10013 USA
关键词
D O I
10.1001/archinte.155.14.1537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Depletion of circulating CD4(+) T lymphocytes among persons infected with the human immuno-deficiency virus (HIV) is associated with increased risk for development of opportunistic, life-threatening diseases and death. Methods: To describe the levels of CD4(+) T lymphocytes at which acquired immunodeficiency syndrome (AIDS)-defining and other illnesses initially occur, we analyzed data from an ongoing survey of medical records of 18 062 HIV-infected patients who received medical care between January 1990 and August 1993 in more than 100 clinics, hospitals, and private practices in 10 US cities. We report the median and upper 80th percentile CD4(+) T-lymphocyte counts at diagnosis. Results: We found that AIDS-defining conditions first occurred in HIV-infected patients with CD4(+) T-lymphocyte counts below 0.20 X10(9)/L (200/mu L) for 80% of diagnoses. Similarly, AIDS-defining diseases occurred at counts below 0.05x10(9)/L for 50% of diagnoses. Exceptions to both criteria were invasive cervical cancer and pulmonary tuberculosis. Non-AIDS-defining illnesses with which 80% of patients were diagnosed at CD4(+) T-lymphocyte counts below 0.20X10(9)/L were bacterial sepsis and retinopathy (excluding cytomegalovirus). Conclusion: Our observations support the need for continued CD4(+) cell count monitoring below a level of 0.20X10(9)/L as a guide to diagnosis and medical management of HIV-infected persons.
引用
收藏
页码:1537 / 1542
页数:6
相关论文
共 38 条
[1]  
CHAISSON RE, 1993, AIDS, V7, P857, DOI 10.1097/00002030-199306000-00015
[2]  
CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770
[3]   HEART INVOLVEMENT IN AIDS - A PROSPECTIVE-STUDY DURING VARIOUS STAGES OF THE DISEASE [J].
DECASTRO, S ;
MIGLIAU, G ;
SILVESTRI, A ;
DAMATI, G ;
GIANNANTONI, P ;
CARTONI, D ;
KOL, A ;
VULLO, V ;
CIRELLI, A .
EUROPEAN HEART JOURNAL, 1992, 13 (11) :1452-1459
[4]   PREDICTIVE MARKERS FOR THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) IN HEMOPHILIACS - PERSISTENCE OF P24 ANTIGEN AND LOW T4 CELL COUNT [J].
EYSTER, ME ;
BALLARD, JO ;
GAIL, MH ;
DRUMMOND, JE ;
GOEDERT, JJ .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (12) :963-969
[5]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[6]  
FARIZO K, 1992, J WOMEN HLTH, V1, P193
[7]  
FARIZO KM, 1992, JAMA-J AM MED ASSOC, V267, P1798, DOI 10.1001/jama.267.13.1798
[8]  
FERNANDEZCRUZ E, 1990, AIDS, V4, P987, DOI 10.1097/00002030-199010000-00007
[9]   THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
HANSEN, N ;
COLLIER, AC ;
CAREY, JT ;
PARA, MF ;
HARDY, WD ;
DOLIN, R ;
POWDERLY, WG ;
ALLAN, JD ;
WONG, B ;
MERIGAN, TC ;
MCAULIFFE, VJ ;
HYSLOP, NE ;
RHAME, FS ;
BALFOUR, HH ;
SPECTOR, SA ;
VOLBERDING, P ;
PETTINELLI, C ;
ANDERSON, J .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737
[10]   HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND THE KIDNEY [J].
GLASSOCK, RJ ;
COHEN, AH ;
DANOVITCH, G ;
PARSA, KP .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (01) :35-49